原位肝移植术中输注血浆对术后急性肾损伤发生率的影响

Influence of plasma infusion during orthotopic liver transplantation on the incidence of postoperative acute kidney injury

  • 摘要:
    目的  探讨原位肝移植术中输注血浆对受者术后急性肾损伤(AKI)发生率的影响。
    方法  回顾性收集2016年1月至2020年12月于首都医科大学附属北京朝阳医院接受原位肝移植术患者的临床资料。研究共纳入473例肝移植受者,包括术中输注血浆者354例(血浆组)与术中未输注血浆者119例(对照组)。分析比较两组患者术前情况、供者情况、患者术中情况、主要结局指标和次要结局指标。绘制受试者工作特征曲线计算影响术后7 d内发生的AKI术中血浆输注量最大截断值,logistic回归分析术中血浆输注量与术后7 d内AKI发生率的相关性。
    结果  倾向性评分匹配前,血浆组术后7 d内AKI发生率和Ⅲ级AKI发生率均高于对照组(均为P<0.05)。倾向性评分匹配后两组分别纳入受者62例,血浆组受者术后7 d内AKI发生率与对照组差异无统计学意义,但血浆组受者术后7 d内Ⅲ级AKI发生率高于对照组(P=0.041)。logistic回归分析显示,术中血浆输注量>900 mL是术后7 d内发生AKI的潜在危险因素(比值比=1.936,95%可信区间1.193~3.142,P=0.007)。倾向性评分匹配前后两组受者术后365 d病死率、再灌注后综合征及术后30 d并发症等发生率差异均无统计学意义。此外,匹配前后血浆组术后白蛋白、纤维蛋白原水平和国际标准化比值均优于对照组(均为P<0.05)。
    结论  原位肝移植术中输注血浆量大与术后Ⅲ级AKI的发生风险增加相关,血浆输注量超过900 mL可能增加术后7 d内AKI发生风险。

     

    Abstract:
    Objective  To investigate the influence of plasma infusion during orthotopic liver transplantation on the incidence of acute kidney injury (AKI) in recipients.
    Methods  Cinical data of 473 liver transplant recipients who underwent orthotopic liver transplantation at Beijing Chaoyang Hospital Affiliate to Capital Medical University from January 2016 to December 2020 were retrospectively collected. The study included 354 recipients who received plasma infusion during the operation (plasma group) and 119 recipients who did not receive plasma infusion during the operation (control group). Preoperative conditions, donor conditions, intraoperative conditions, main outcome indicators and secondary outcome indicators of the two groups were analyzed and compared. Receiver operating characteristic curve was drawn to calculate the maximum cut-off value of intraoperative plasma infusion volume that affected the occurrence of AKI within 7 days after surgery. Logistic regression analysis was performed to analyze the correlation between intraoperative plasma infusion volume and the incidence of AKI within 7 days after surgery.
    Results  Before propensity score matching, the incidence of AKI within 7 days after surgery and the incidence of grade Ⅲ AKI in the plasma group were higher than those in the control group (both P<0.05). After propensity score matching, 62 recipients were included in each group. There was no statistically significant difference in the incidence of AKI within 7 days after surgery between the plasma group and the control group, but the incidence of grade Ⅲ AKI within 7 days after surgery in the plasma group was higher than that in the control group (P=0.041). Logistic regression analysis showed that intraoperative plasma infusion volume >900 mL was a potential risk factor for AKI within 7 days after surgery (odds ratio=1.936, 95% confidence interval 1.193-3.142, P=0.007). There were no statistically significant differences in the incidence of 365-day postoperative fatality, reperfusion syndrome, and postoperative 30-day complications between the two groups before and after propensity score matching. In addition, the postoperative albumin, fibrinogen levels, and international normalized ratio in the plasma group were better than those in the control group before and after matching (all P<0.05).
    Conclusions  Large amount of intraoperative plasma infusion is associated with an increased risk of grade Ⅲ AKI after orthotopic liver transplantation. Intraoperative plasma infusion volume >900 mL may increase the risk of AKI within 7 days after surgery.

     

/

返回文章
返回